Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Cryptococcus gattii induces a cytokine pattern that is distinct from other cryptococcal species.

Schoffelen T, Illnait-Zaragozi MT, Joosten LA, Netea MG, Boekhout T, Meis JF, Sprong T.

PLoS One. 2013;8(1):e55579. doi: 10.1371/journal.pone.0055579. Epub 2013 Jan 31.

2.

In vitro antifungal susceptibility profiles and genotypes of 308 clinical and environmental isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii serotype B from north-western India.

Chowdhary A, Randhawa HS, Sundar G, Kathuria S, Prakash A, Khan Z, Sun S, Xu J.

J Med Microbiol. 2011 Jul;60(Pt 7):961-7. doi: 10.1099/jmm.0.029025-0. Epub 2011 Mar 10.

PMID:
21393452
3.

Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients.

Saijo T, Chen J, Chen SC, Rosen LB, Yi J, Sorrell TC, Bennett JE, Holland SM, Browne SK, Kwon-Chung KJ.

MBio. 2014 Mar 18;5(2):e00912-14. doi: 10.1128/mBio.00912-14.

4.

Taxonomic analysis of cryptococcus species complex strain S8012 revealed Cryptococcus gattii with high heterogeneity on the genetics.

Chen M, Liao WQ, Wu SX, Yao ZR, Pan WH, Liao Y.

Chin Med J (Engl). 2011 Jul 5;124(13):2051-6.

PMID:
22088469
5.

Rapid identification of Cryptococcus neoformans var. grubii, C. neoformans var. neoformans, and C. gattii by use of rapid biochemical tests, differential media, and DNA sequencing.

McTaggart L, Richardson SE, Seah C, Hoang L, Fothergill A, Zhang SX.

J Clin Microbiol. 2011 Jul;49(7):2522-7. doi: 10.1128/JCM.00502-11. Epub 2011 May 18.

6.

Seasonal variations in the prevalence of Cryptococcus neoformans var. grubii and Cryptococcus gattii in decayed wood inside trunk hollows of diverse tree species in north-western India: a retrospective study.

Randhawa HS, Kowshik T, Chowdhary A, Prakash A, Khan ZU, Xu J.

Med Mycol. 2011 Apr;49(3):320-3. doi: 10.3109/13693786.2010.516457. Epub 2010 Sep 21.

PMID:
20854229
7.

Enzymatic characterisation of clinical isolates of Cryptococcus neoformans, Cryptococcus gattii and other environmental Cryptococcus spp.

Chan MY, Tay ST.

Mycoses. 2010 Jan;53(1):26-31. doi: 10.1111/j.1439-0507.2008.01654.x. Epub 2009 Mar 15.

PMID:
19389064
8.

Seasonal prevalence of Cryptococcus neoformans var. grubii and Cryptococcus gattii inhabiting Eucalyptus terreticornis and Eucalyptus camaldulensis trees in Jabalpur City of Madhya Pradesh, Central India.

Bedi NG, Nawange SR, Singh SM, Naidu J, Kavishwar A.

J Mycol Med. 2012 Dec;22(4):341-7. doi: 10.1016/j.mycmed.2012.09.001. Epub 2012 Nov 2.

PMID:
23518169
9.

Experimental systemic infection with Cryptococcus neoformans var. grubii and Cryptococcus gattii in normal and immunodeficient mice.

Capilla J, Maffei CM, Clemons KV, Sobel RA, Stevens DA.

Med Mycol. 2006 Nov;44(7):601-10.

PMID:
17071553
10.

Environmental prevalence of Cryptococcus neoformans and Cryptococcus gattii in India: an update.

Chowdhary A, Rhandhawa HS, Prakash A, Meis JF.

Crit Rev Microbiol. 2012 Feb;38(1):1-16. doi: 10.3109/1040841X.2011.606426. Epub 2011 Dec 1. Review.

PMID:
22133016
11.

Infective capacity of Cryptococcus neoformans and Cryptococcus gattii in a human astrocytoma cell line.

Olave MC, Vargas-Zambrano JC, Celis AM, Castañeda E, González JM.

Mycoses. 2017 Jul;60(7):447-453. doi: 10.1111/myc.12619. Epub 2017 Mar 24.

PMID:
28338245
13.
14.

Cryptococcus gattii infection dampens Th1 and Th17 responses by attenuating dendritic cell function and pulmonary chemokine expression in the immunocompetent hosts.

Angkasekwinai P, Sringkarin N, Supasorn O, Fungkrajai M, Wang YH, Chayakulkeeree M, Ngamskulrungroj P, Angkasekwinai N, Pattanapanyasat K.

Infect Immun. 2014 Sep;82(9):3880-90. doi: 10.1128/IAI.01773-14. Epub 2014 Jun 30.

15.

MALDI-TOF MS enables the rapid identification of the major molecular types within the Cryptococcus neoformans/C. gattii species complex.

Firacative C, Trilles L, Meyer W.

PLoS One. 2012;7(5):e37566. doi: 10.1371/journal.pone.0037566. Epub 2012 May 29.

16.

Identification of Cryptococcus gattii by use of L-canavanine glycine bromothymol blue medium and DNA sequencing.

Klein KR, Hall L, Deml SM, Rysavy JM, Wohlfiel SL, Wengenack NL.

J Clin Microbiol. 2009 Nov;47(11):3669-72. doi: 10.1128/JCM.01072-09. Epub 2009 Sep 30.

17.

Altered immune response differentially enhances susceptibility to Cryptococcus neoformans and Cryptococcus gattii infection in mice expressing the HIV-1 transgene.

Leongson K, Cousineau-Côté V, Goupil M, Aumont F, Sénéchal S, Gaboury L, Jolicoeur P, Kronstad JW, de Repentigny L.

Infect Immun. 2013 Apr;81(4):1100-13. doi: 10.1128/IAI.01339-12. Epub 2013 Jan 22.

18.

Evasion of Innate Immune Responses by the Highly Virulent Cryptococcus gattii by Altering Capsule Glucuronoxylomannan Structure.

Urai M, Kaneko Y, Ueno K, Okubo Y, Aizawa T, Fukazawa H, Sugita T, Ohno H, Shibuya K, Kinjo Y, Miyazaki Y.

Front Cell Infect Microbiol. 2016 Jan 6;5:101. doi: 10.3389/fcimb.2015.00101. eCollection 2015.

19.
20.

Molecular typing and antifungal susceptibility of clinical and environmental Cryptococcus neoformans species complex isolates in Goiania, Brazil.

Souza LK, Souza Junior AH, Costa CR, Faganello J, Vainstein MH, Chagas AL, Souza AC, Silva MR.

Mycoses. 2010 Jan;53(1):62-7. doi: 10.1111/j.1439-0507.2008.01662.x. Epub 2009 Jun 4.

PMID:
19500261

Supplemental Content

Support Center